The Central Association for Digital Healthcare (SVDGV) will have a new managing director, Dr. Anne Sophie Geier, who will head the association’s fortunes on October 1, 2020. Geier would like to establish the still young industry as a new pillar of healthcare in Germany in the long term, as she herself has said. The industry expert and doctor of pharmacy, who is only 34 years old, studied pharmacy in Münster at the Westphalian Wilhelms University (WWU) there and then earned her doctorate at Harvard Medical School. She then worked for a long time as a management consultant in a pharmaceutical company before she became head of department at the GKV-Spitzenverband (the leading association of statutory health insurance companies) and was entrusted with the benefit assessment of newly approved drugs. 80 e-health companies are networked as members of the SVDGV so that digital innovations and health applications can be included in the standard care of the German population on a sustainable and equal basis. For Geier, as the dream candidate of many, this is a new and large area of responsibility, but one that she can probably accomplish with good and extensive industry networking and a great deal of passion thanks to her visionary qualities. She is to represent the interests and concerns of the individual members and provide evidence of the benefits of digital healthcare products so that they can support high-quality and efficient healthcare. With her expertise, she will be able to represent digital healthcare solutions in politics and the public, as is certain at the association in Berlin, where the pharmacist was first entrusted with setting up the office.
